Irritable bowel syndrome: The Lancet Gastroenterology & Hepatology: Feb 2017

FromThe Lancet Gastroenterology & Hepatology in conversation with

Start listening View podcast show

Irritable bowel syndrome: The Lancet Gastroenterology & Hepatology: Feb 2017

FromThe Lancet Gastroenterology & Hepatology in conversation with

ratings:

Length:

11 minutes

Released:

Jan 12, 2017

Format:

Podcast episode

Description

Magnus Simrén comprehensively reviews treatments and therapies for irritable bowel syndrome.

Released:

Jan 12, 2017

Format:

Podcast episode

Titles in the series (75)

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

Irritable bowel syndrome: The Lancet Gastroenterology & Hepatology: Feb 2017 by The Lancet Gastroenterology & Hepatology in conversation with
11 min listen
Barrett's oesophagus: The Lancet Gastroenterology & Hepatology: Jan 2017 by The Lancet Gastroenterology & Hepatology in conversation with
12 min listen
Acute hepatitis C by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
Neurostimulation for abdominal pain: The Lancet Gastroenterology & Hepatology: August 18, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Migraine and GI disorders: The Lancet Gastroenterology & Hepatology: September 7, 2016 by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
Oral immunotherapy: The Lancet Gastroenterology & Hepatology: February 2018 by The Lancet Gastroenterology & Hepatology in conversation with
19 min listen
Global prevalence, treatment, and prevention of hepatitis B virus infection by The Lancet Gastroenterology & Hepatology in conversation with
13 min listen
Reducing population alcohol consumption: The Lancet Gastroenterology & Hepatology: August 10, 2016 by The Lancet Gastroenterology & Hepatology in conversation with
19 min listen
PROTECT study: The Lancet Gastroenterology & Hepatology: December 2017 by The Lancet Gastroenterology & Hepatology in conversation with
12 min listen
Treatment and reinfection risk for hepatitis C treatment: The Lancet Gastroenterology & Hepatology: February 8, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
12 min listen
Faecal transplantation: The Lancet Gastroenterology & Hepatology: Jan 2018 by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
HALT-HCC score: The Lancet Gastroenterology & Hepatology: July 5, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
Inflammatory bowel disease: The Lancet Gastroenterology & Hepatology: December issue by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Stem cell transplantation in Crohn's: The Lancet Gastroenterology & Hepatology: May 5, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
12 min listen
Treatment of an appendix mass in children: The Lancet Gastroenterology & Hepatology: March 8, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
9 min listen
Whole-body MRI: the STREAMLINE trials by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Oesophageal motility and solid meal tests: The Lancet Gastroenterology & Hepatology: August 2, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Primary anastomosis as a treatment for diverticulitis by The Lancet Gastroenterology & Hepatology in conversation with
8 min listen
Viral hepatitis in migrant populations by The Lancet Gastroenterology & Hepatology in conversation with
4 min listen
Can DAA therapy for HCV reactivate HBV in coinfected patients? by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
UDCA Response Score by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
DAA treatment for hepatitis C among people who inject drugs by The Lancet Gastroenterology & Hepatology in conversation with
11 min listen
A new drug for short bowel syndrome by The Lancet Gastroenterology & Hepatology in conversation with
11 min listen
Research priorities in Barrett's and GORD: The Lancet Gastroenterology & Hepatology: August 31, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
22 min listen
Early intervention for alcohol-related liver disease: The Lancet Gastroenterology and Hepatology: June 7, 2017 by The Lancet Gastroenterology & Hepatology in conversation with
13 min listen
Caroline Ovadia on intrahepatic cholestasis of pregnancy by The Lancet Gastroenterology & Hepatology in conversation with
12 min listen
Statins and decompensated cirrhosis by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen
Viral hepatitis in children & adolescents by The Lancet Gastroenterology & Hepatology in conversation with
25 min listen
Neoplasia detection in ulcerative colitis by The Lancet Gastroenterology & Hepatology in conversation with
9 min listen
Transplanting hepatitis C-infected hearts by The Lancet Gastroenterology & Hepatology in conversation with
7 min listen

More Episodes from The Lancet Gastroenterology & Hepatology in conversation with

Skip carousel

Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS by The Lancet Gastroenterology & Hepatology in conversation with
23 min listen
Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease by The Lancet Gastroenterology & Hepatology in conversation with
20 min listen
Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa by The Lancet Gastroenterology & Hepatology in conversation with
21 min listen
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake by The Lancet Gastroenterology & Hepatology in conversation with
17 min listen
Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity by The Lancet Gastroenterology & Hepatology in conversation with
23 min listen
Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Anna Kann on the causes of mortality in patients with alcohol-related liver disease by The Lancet Gastroenterology & Hepatology in conversation with
16 min listen
Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction by The Lancet Gastroenterology & Hepatology in conversation with
17 min listen
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis by The Lancet Gastroenterology & Hepatology in conversation with
14 min listen
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease by The Lancet Gastroenterology & Hepatology in conversation with
18 min listen
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis by The Lancet Gastroenterology & Hepatology in conversation with
13 min listen
Adelina Artenie on the incidence of HIV and HCV in people who inject drugs by The Lancet Gastroenterology & Hepatology in conversation with
17 min listen
Johan Burisch on the costs of inflammatory bowel disease in high-income settings by The Lancet Gastroenterology & Hepatology in conversation with
20 min listen
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease by The Lancet Gastroenterology & Hepatology in conversation with
22 min listen
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer by The Lancet Gastroenterology & Hepatology in conversation with
20 min listen
Dan Turner on vedolizumab in children with IBD by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
James Alexander immune responses to COVID-19 vaccination in patients with IBD by The Lancet Gastroenterology & Hepatology in conversation with
14 min listen
Filip Knop on liraglutide for bile acid diarrhoea by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma by The Lancet Gastroenterology & Hepatology in conversation with
14 min listen
Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Juan Pablo Arab on NAFLD public health policies in the Americas by The Lancet Gastroenterology & Hepatology in conversation with
17 min listen
Sarah Blach on hepatitis C virus epidemiology by The Lancet Gastroenterology & Hepatology in conversation with
9 min listen
Sunil Solomon on a minimal monitoring approach for hepatitis C virus infection by The Lancet Gastroenterology & Hepatology in conversation with
15 min listen
Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis by The Lancet Gastroenterology & Hepatology in conversation with
14 min listen
Swati Patel on early-onset colorectal cancer by The Lancet Gastroenterology & Hepatology in conversation with
19 min listen
Emilie Breekveldt on FIT-based screening for colorectal cancer in the Netherlands by The Lancet Gastroenterology & Hepatology in conversation with
10 min listen
Wendy Spearman on non-alcoholic fatty liver disease in sub-Saharan Africa by The Lancet Gastroenterology & Hepatology in conversation with
23 min listen

Discover this podcast and so much more

Irritable bowel syndrome: The Lancet Gastroenterology & Hepatology: Feb 2017

Irritable bowel syndrome: The Lancet Gastroenterology & Hepatology: Feb 2017

Description

Titles in the series (75)

More Episodes from The Lancet Gastroenterology & Hepatology in conversation with